Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer. Jul 2002 - Expert Rev Anticancer Ther; 2(1):1473-7140 [PMID:12113075] [Cannon MJ] [O'Brien TJ] [Underwood LJ] [Crew MD] [Bondurant KL] [Santin AD]